News

LNC Therapeutics chooses Luina Bio for the development and GMP manufacturing of its first live bio...

Oct 22, 2019

LNC Therapeutics raises €6.2 million for the clinical development of new generation drugs based on...

Sep 5, 2019

LNC Therapeutics announces the deployment of a research platform focused exclusively on its gut...

Jun 6, 2019

LNC Therapeutics announces the grant of the first worldwide patent relating to the therapeutic...

Mar 26, 2019

Dr. Mathieu Simon and Catherine Combot-Plétan join the Board of Directors of biotech firm LNC...

Dec 11, 2018

LNC Therapeutics acquires exclusive license for the Christensenella patent from Cornell University

Oct 15, 2018